Quantcast
Last updated on April 21, 2014 at 10:27 EDT

Latest Opioid Stories

2012-08-02 10:27:25

SAN FRANCISCO, Calif., Aug. 2, 2012 /PRNewswire/ -- Nektar Therapeutics (Nasdaq: NKTR) will announce its financial results for the second quarter ended June 30, 2012 on Thursday, August 9, 2012, after the close of U.S.-based financial markets. Howard Robin, president and chief executive officer, will host a conference call to review the results beginning at 5:00 p.m. Eastern Time (ET)/2:00 p.m. Pacific Time (PT). The press release and a live audio-only Webcast of the conference call can be...

2012-08-01 06:22:32

NEW YORK, Aug. 1, 2012 /PRNewswire/ -- The American Society of Interventional Pain Physicians (ASIPP), a national medical society of over 4,000 members, has released its "Guidelines for Responsible Opioid Prescribing in Chronic Non-Cancer Pain." A multidisciplinary panel of 55 medical experts drafted this comprehensive two-part guideline to improve patient care, curtail the abuse of opioids without jeopardizing non-cancer pain management treatments, and improve understanding among law...

2012-07-17 22:22:50

CAMBRIDGE, England, July 18, 2012 /PRNewswire/ -- Phase I study data indicates CNV2197944's optimal profile for a chronic pain medication Convergence Pharmaceuticals Limited ("Convergence"), the company focused on the development of novel and high value analgesic medicines for the treatment of chronic pain, today announces that it is designing Phase II proof of concept studies with CNV2197944 in neuropathic pain, following...

2012-07-17 10:24:11

New patient-friendly web site launches to commemorate second anniversary of daughter's death GRANGER, Ind., July 17, 2012 /PRNewswire-USNewswire/ -- The Promise to Amanda Foundation, created by Cindy and Brian Abbiehl in honor of their daughter Amanda, who died 2 years ago while on an intravenous patient-controlled analgesia pain pump, (IV PCA pain pump), announced today the launch of their new website www.promisetoamanda.org dedicated to raising awareness to hospitals and the general...

2012-07-09 14:23:16

STAMFORD, Conn., July 9, 2012 /PRNewswire/ -- The U.S. Food and Drug Administration (FDA) is requiring opioid analgesic companies to implement a new, shared Risk Evaluation & Mitigation Strategy (REMS) for all extended-release and long-acting opioid pain medications to ensure that the benefits continue to outweigh the risks of adverse outcomes (addiction, unintentional overdose, and death) resulting from inappropriate prescribing, abuse, and misuse. The principal components of this REMS...

2012-07-06 10:55:17

Frequently recommended in weight-loss diets, dietary proteins have proven effectiveness thanks to their appetite-suppressing effects. A team led by Gilles Mithieux, Director of Inserm's Unit 855 "Nutrition and the Brain" in Lyon, has managed to explain the biological mechanisms behind these properties. The researchers describe in detail the chain reactions triggered by digesting proteins, sending a 'satiety' message to the brain long after a meal. Their results will make it possible envisage...

2012-07-06 10:25:40

Researchers decode a molecular mechanism that sheds light on how trauma can become engraved in the brain Feelings of anxiety very effectively prevent people from getting into situations that are too dangerous. Those who have had a terrible experience initially tend to avoid the place of tragedy out of fear. If no other oppressive situation arises, normally the symptoms of fear gradually subside. "The memory of the terrible events is not just erased." states first author, PD Dr. Andras...

2012-06-28 02:27:38

RALEIGH, N.C., June 28, 2012 /PRNewswire/ -- BioDelivery Sciences International, Inc. (NASDAQ: BDSI) announced positive results of a recently completed pharmacokinetic study (BNX-106) examining the effects of multiple BEMA Buprenorphine/Naloxone (BNX) films administered concurrently. This study was part of the U.S. Food and Drug Administration (FDA) recommended program for a New Drug Application (NDA) for BNX. (Logo: http://photos.prnewswire.com/prnh/20110217/CL49801LOGO ) The study...

2012-06-25 02:26:10

SHIRLEY, N.Y., June 25, 2012 /PRNewswire/ -- Regency Therapeutics, a division of Luitpold Pharmaceuticals, Inc., announced today that a national registry has been launched by a group of academic emergency medicine specialists led by Charles Pollack, MA, MD, FAAEM, FACEP, FAHA, Professor and Chairman, Department of Emergency Medicine, Pennsylvania Hospital, University of Pennsylvania Health System. The purpose of the registry is to evaluate patient experience with...

2012-06-15 23:00:41

Normally used in clinical settings, Puridone has been recently released to the general public online as a 60-day "in home" treatment to help those dealing with opiate dependency and painkiller addiction. In clinical studies conducted in 2012, Puridone demonstrated a remarkable increase in energy, sleep and sex drive, while simultaneously lowering withdrawal symptoms, anxiety and depression scores. Jamison, PA (PRWEB) June 15, 2012 The Puridone Program is an incredible new proprietary...